Press monitoring
Tecan to expand its Partnering Business with acquisition of Sias
28.10.2015 | Press monitoring
Männedorf, Switzerland, October 28, 2015 - The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has reached agreement with the majority shareholders of Sias to acquire Sias AG, a leading OEM supplier of a wide range of modular and complete laboratory automation solutions. Sias will become a part of Tecan's Partnering Business,...
Cleveland Clinic Names Stent Retriever Technology One of the Top Medical Innovations for 2016
28.10.2015 | Press monitoring
DUBLIN - October 28, 2015 - The Cleveland Clinic has named stent retriever technology, which includes Medtronic plc 's (NYSE: MDT) Solitaire TM stent retriever device, to a list of the top medical innovations for 2016. The top medical innovations list was revealed today at the Cleveland Clinic's 2015 Medical Innovation Summit. ...
Bavarian Nordic Applauds Recommendations Outlined by U.S. Blue Ribbon Study Panel on Biodefense
28.10.2015 | Press monitoring
COPENHAGEN, Denmark, October 28, 2015 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today applauds the Blue Ribbon Study Panel on Biodefense for its comprehensive assessment of the biological threats facing the United States, as well as its clear recommendations for action to improve the level of preparedness to respond to those ...
CRISPR tweak may help gene-edited crops bypass biosafety regulation
28.10.2015 | Press monitoring
A twist on a revolutionary gene-editing technique may make it possible to modify plant genomes while sidestepping national biosafety regulations, South Korean researchers say. Plant scientists have been quick to experiment with the popular CRISPR/Cas9 technique, which uses an enzyme called Cas9, guided by two RNA strands, to precisely cut...
23andMe relaunches direct-to-consumer tests for genetic disease
26.10.2015 | Press monitoring
23andMe is relaunching its direct-to-consumer genetic tests after gaining government approval for a more limited array of tests to inform you about your risk of passing on a genetic disease. In 2013, the company was banned from selling a genetic test that provided customers with information about their risk of developing 254 conditions, including...
Could a drug engineered from bananas fight many deadly viruses?
23.10.2015 | Press monitoring
A banana a day may not keep the doctor away, but a substance originally found in bananas and carefully edited by scientists could someday fight off a wide range of viruses, new research suggests. And the process used to create the virus-fighting form may help scientists develop even more drugs, by harnessing the "sugar code" that our cells use...
How plants turn into zombies
21.10.2015 | Press monitoring
Scientists from Jena University (Germany) shed light on the molecular reasons for a bacterial plant disease: In the latest issue of the science journal Trends in Plant Science, the researchers explain how phytoplasmas destroy the life cycle of plants and inflict a 'zombie' existence on them. "The insects transmit bacteria, so-called...
Introducing the mighty panoramix: Defender of genomes
19.10.2015 | Press monitoring
Organisms from bacteria to humans must defend themselves against parasitic genetic elements called transposons, and the stakes are high. These pieces of DNA, which disrupt genes by jumping around in the genome, can cause so much destruction that cells have dedicated surveillance mechanisms to keep them in check. To protect future generations...
A better way to read the genome
16.10.2015 | Press monitoring
UConn researchers have sequenced the RNA of the most complicated gene known in nature, using a hand-held sequencer no bigger than a cell phone. Genomicists from the UConn Institute of Systems Genomics teamed up with UK-based Oxford Nanopore Technologies to show that the company's MinION nanopore sequencer can sequence genes faster, better, and...
Medtronic CoreValve® Evolut® R System Demonstrates Exceptional Results at One Year
15.10.2015 | Press monitoring
DUBLIN and SAN FRANCISCO - October 14, 2015 - Medtronic plc (NYSE: MDT) announced new one-year data showing transcatheter aortic valve replacement (TAVR) with the CoreValve ® Evolut ® R System-the first and only next-generation recapturable, self-expanding valve available in the U.S.-led to exceptional clinical outcomes. ....
